# Goodbody Health rolls out blood testing technology

- Link: https://www.directorstalkinterviews.com/goodbody-health-rolls-out-blood-testing-technology/4121055828
- Published: 2022-03-08T07:13:22+00:00
- Author: Giles

**Goodbody Health Inc** ([AQSE:GDBY](https://www.directorstalkinterviews.com/company/goodbody-health/gdby.cn))
has announced that, following a successful pilot project using new technology to
deliver accessible, fast (available in less than 10 minutes) blood test results 
in the local community, it has ordered a first tranche of 100 Abbott blood testing
machines for its existing UK clinic network.

Using the Abbott Machines, Goodbody Health will administer blood tests with respect
to lipids (heart / cholesterol) and diabetes through the Company’s clinics. By identifying
issues relating to heart health and diabetes through its blood testing, the Company
hopes to help customers take control through making healthy lifestyle changes and
further the Company’s mission of helping people ‘know more, live better’.

According to Diabetes UK (https://www.diabetes.org.uk/professionals/position-statements-
reports/statistics), more than 4.9 million people have diabetes in the UK with 850,000
currently living with Type 2 diabetes yet to be diagnosed. If nothing changes, they
predict that 5.5 million people will have diabetes in the UK by 2023.

According to Public Health England (https://www.gov.uk/government/publications/health-
matters-preventing-cardiovascular-disease/health-matters-preventing-cardiovascular-
disease), one in four deaths in England, based on data from 2016, was caused by 
cardiovascular disease. Following this report, Public Health England estimates ongoing
Healthcare costs in England will amount to £7.4 billion per year. 

In January, Parliament’s health and social care committee said the NHS faces an “
unquantifiable challenge” to deal with patients who have not been treated because
many have health conditions that have yet to be identified.  Pointing to figures
showing that 5.8 million patients are waiting for planned care like routine operations,
he warned that the number “could double by 2025” and that the NHS faces an “unquantifiable
challenge in tackling a backlog of cases caused by the pandemic”.

With the phase one rollout of the Abbott Machines, Goodbody Health will be able 
to offer blood testing in over 150 UK locations through its clinic network and its
partnership with Superdrug.

> **Geremy Thomas, Goodbody Health Executive Chairman, said:** “I am pleased that
> we are able to use technology, in the local community, to offer customers the 
> opportunity to undertake a fast health check of their blood, the results of which
> can enable them to make decisions to improve their lives.”

Share on:
